Ingersoll Rand Reports First-Quarter 2022 Results
Ingersoll Rand reported a strong first-quarter performance for 2022, showcasing record orders of $1,630 million, up 25%, and revenues of $1,337 million, up 18%. Net income rose to $104 million, or $0.25 per share, reflecting a 215% increase from the previous year's loss. The company raised its 2022 guidance for organic revenue growth to 8%-10% and adjusted EBITDA to $1,385-$1,425 million, an increase of 16%-20% year over year. Liquidity remains strong at $3.1 billion as of March 31, 2022.
- Record orders of $1,630 million, up 25% year over year.
- Revenue growth of $1,337 million, an increase of 18%.
- Net income increased to $104 million, or $0.25 per share, up 215%.
- Adjusted EBITDA grew to $304 million, up 24%, with a margin of 22.7%.
- Raised 2022 organic revenue growth guidance to 8%-10%.
- Free cash flow decreased to $32 million compared to $73 million in the previous year.
- Adjusted EBITDA margin decreased in the Precision and Science Technologies segment, impacting profitability.
Strong Double-Digit Orders and Revenue Growth; Raising 2022 Guidance
First-Quarter 2022 Highlights
(All comparisons against the first-quarter of 2021 unless otherwise noted.)
Strong performance driven by its competitive differentiator - Ingersoll Rand Execution Excellence (IRX):
-
Record orders of
, up$1,630 million 25% , or21% organic
-
Record first-quarter revenues of
, up$1,337 million 18% , or14% organic
-
Reported net income attributable to
Ingersoll Rand of , or earnings of$104 million per share, up$0.25 215% from prior year net loss attributable toIngersoll Rand of$90 million -
Adjusted net income from continuing operations, net of tax1 of
, or$201 million per share$0.49
-
Adjusted net income from continuing operations, net of tax1 of
-
Adjusted EBITDA1 of
, up$304 million 24% , with a margin of22.7% and incremental margin of29%
-
Reported operating cash flow from continuing operations of
and free cash flow from continuing operations of$50 million $32 million
-
Liquidity of
as of$3.1 billion March 31, 2022 , including of cash on hand and undrawn capacity of$2.0 billion under available credit facilities$1.1 billion
-
Acquired Jorc, a manufacturer of condensate management systems for environmental applications, for
€27 million
-
Repurchased 2.1 million shares for
$101 million
2022 Guidance
-
Raising full-year 2022 organic revenue growth expectation by 100 bps to
8% to10% , affirming total revenue growth of11% to13% and raising Adjusted EBITDA1 range to to$1,385 , up$1,425 million 16% to20% over the prior year
“Our strong first-quarter results highlight the resiliency of our business amidst an ever-changing global landscape. Our continued outperformance is enabled by our ability to leverage our operational excellence model, IRX, and to execute on our five strategic imperatives,” said
First-Quarter 2022 Segment Review
(All comparisons against the first quarter of 2021 unless otherwise noted.)
Industrial Technologies and Services Segment: broad range of compressor, vacuum and blower solutions as well as fluid transfer equipment, loading systems, power tools and lifting equipment
-
Reported Orders of
, up$1,293 million 24% , or25% organic
-
Reported Revenues of
, up$1,040 million 14% both as reported and organic
-
Reported Segment Adjusted EBITDA of
, up$247 million 17% with an incremental margin of29%
-
Reported Segment Adjusted EBITDA Margin of
23.8% , up 70 basis points, fueled by the use of IRX to drive execution and realization of transaction synergies
-
Core industrial end markets saw continued strong demand with orders up
24% as compared to prior year, including strong positive momentum across all major regions. Orders for total compressor offerings, which represent approximately65% of the total segment, grew approximately30% , while orders in Industrial Vacuum & Blowers were up more than20% . Orders in Power Tools and Lifting were up more than15% .
Precision and Science Technologies Segment: highly specialized gas, fluid management systems, liquid and precision syringe pumps and compressors
-
Reported Orders of
, up$337 million 31% , or6% organic
-
Reported Revenues of
, up$297 million 38% , or12% organic
-
Reported Segment Adjusted EBITDA of
, up$85 million 27% with an incremental margin of22%
-
Reported Segment Adjusted EBITDA Margin of
28.6% , down 260 basis points, driven primarily by the impact of theSeepex and Maximus Solutions acquisitions
-
Orders increased
31% as compared to prior year led by strong double-digit growth from the YZ Systems,Milton Roy ® and ARO® product lines, all of which primarily serve industrial end markets. Orders were also positively impacted by theSeepex , Maximus Solutions, Tuthill Pumps and Air Dimensions acquisitions.
Balance Sheet and Cash Flow
Ingersoll Rand remains in a strong financial position with ample liquidity of
2022 Guidance
Ingersoll Rand is raising 2022 guidance based on expected continued strong demand trends and operational execution in 2022:
Total Ingersoll Rand |
Initial 2022
|
Revised Guidance |
Phasing |
|
Revenue Growth |
11 |
11 |
H1: 12 |
|
Total IR Organic |
7 |
8 |
|
|
ITS Organic |
7 |
8 |
|
|
PST Organic |
8 |
9 |
|
|
FX Impact |
(~ |
(~ |
H1: (~ |
|
M&A |
|
|
|
|
Corporate |
( |
( |
|
|
Adjusted EBITDA |
|
|
|
|
Conference Call
Ingersoll Rand will host a live earnings conference call to discuss the first-quarter results on
Forward-Looking Statements
This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to Ingersoll Rand Inc.’s (the “Company” or “Ingersoll Rand”) expectations regarding the performance of its business, its financial results, its liquidity and capital resources and other non-historical statements. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,” “intend,” “strategy,” “plan,” “may,” “could,” “should,” “will,” “would,” “will be,” “on track to” “will continue,” “will likely result,” “guidance” or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. All statements other than historical facts are forward-looking statements.
These forward-looking statements are based on Ingersoll Rand’s current expectations and are subject to risks and uncertainties, which may cause actual results to differ materially from these current expectations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) the impact on the Company’s business, suppliers and customers and global economic conditions of the COVID-19 pandemic, including business disruptions caused by government restrictions; (2) unexpected costs, charges or expenses resulting from the completed and proposed business combinations; (3) uncertainty of the expected financial performance of the Company; (4) failure to realize the anticipated benefits of the completed and proposed business combinations; (5) the ability of the Company to implement its business strategy; (6) difficulties and delays in achieving revenue and cost synergies; (7) inability of the Company to retain and hire key personnel; (8) evolving legal, regulatory and tax regimes; (9) changes in general economic and/or industry specific conditions; (10) actions by third parties, including government agencies; (11) adverse impact on our operations and financial performance due to natural disaster, catastrophe, pandemic, geopolitical tensions or other events outside of our control; and (12) other risk factors detailed in Ingersoll Rand’s most recent Annual Report on Form 10-K filed with the
Any forward-looking statements speak only as of the date of this release. Ingersoll Rand undertakes no obligation to update any forward-looking statements, whether as a result of new information or development, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on any of these forward-looking statements.
About
Non-
In addition to consolidated GAAP financial measures, Ingersoll Rand reviews various non-GAAP financial measures, including “Organic Revenue Growth,” “Adjusted EBITDA,” “Adjusted Net Income,” “Adjusted Diluted EPS” and “Free Cash Flow.”
Ingersoll Rand believes Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted EPS are helpful supplemental measures to assist management and investors in evaluating the Company’s operating results as they exclude certain items that are unusual in nature or whose fluctuation from period to period do not necessarily correspond to changes in the operations of Ingersoll Rand’s business. Ingersoll Rand believes Organic Revenue Growth is a helpful supplemental measure to assist management and investors in evaluating the Company’s operating results as it excludes the impact of foreign currency and acquisitions on revenue growth. Adjusted EBITDA represents net income before interest, taxes, depreciation, amortization and certain non-cash, non-recurring and other adjustment items. Adjusted Net Income is defined as net income including interest, depreciation and amortization of non-acquisition related intangible assets and excluding other items used to calculate Adjusted EBITDA and further adjusted for the tax effect of these exclusions. Organic Revenue Growth is defined as As Reported Revenue growth less the impacts of Foreign Currency and Acquisitions. Ingersoll Rand believes that the adjustments applied in presenting Adjusted EBITDA and Adjusted Net Income are appropriate to provide additional information to investors about certain material non-cash items and about non-recurring items that the Company does not expect to continue at the same level in the future. Adjusted Diluted EPS is defined as Adjusted Net Income divided by Adjusted Diluted Average Shares Outstanding. Incrementals/Decrementals are defined as the change in Adjusted EBITDA versus the prior year period divided by the change in revenue versus the prior year period.
Ingersoll Rand uses Free Cash Flow to review the liquidity of its operations. Ingersoll Rand measures Free Cash Flow as cash flows from operating activities less capital expenditures. Ingersoll Rand believes Free Cash Flow is a useful supplemental financial measures for management and investors in assessing the Company’s ability to pursue business opportunities and investments and to service its debt. Free Cash Flow is not a measure of our liquidity under GAAP and should not be considered as an alternative to cash flows from operating activities.
Management and Ingersoll Rand’s board of directors regularly use these measures as tools in evaluating the Company’s operating and financial performance and in establishing discretionary annual compensation. Such measures are provided in addition to, and should not be considered to be a substitute for, or superior to, the comparable measures under GAAP. In addition, Ingersoll Rand believes that Organic Revenue Growth, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Incrementals/Decrementals and Free Cash Flow are frequently used by investors and other interested parties in the evaluation of issuers, many of which also present Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, and Free Cash Flow when reporting their results in an effort to facilitate an understanding of their operating and financial results and liquidity.
Organic Revenue Growth, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS and Free Cash Flow should not be considered as alternatives to revenue growth, net income, diluted earnings per share or any other performance measure derived in accordance with GAAP, or as alternatives to cash flow from operating activities as a measure of our liquidity. Organic Revenue Growth, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS and Free Cash Flow have limitations as analytical tools, and you should not consider such measures either in isolation or as substitutes for analyzing Ingersoll Rand’s results as reported under GAAP.
Reconciliations of Organic Revenue Growth, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS and Free Cash Flow to their most comparable
Reconciliations of non-GAAP measures related to full-year 2022 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adjustments that could be made for acquisitions-related expenses, restructuring and other business transformation costs, gains or losses on foreign currency exchange and the timing and magnitude of other amounts in the reconciliation of historic numbers. For the same reasons, we are unable to address the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.
1 Non-GAAP measure (definitions and/or reconciliations in tables below) |
2 Non-GAAP measure (definitions and/or reconciliations in tables below) |
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited; in millions, except per share amounts) |
|||||||
|
For the Three Month Period
|
||||||
|
2022 |
|
2021 |
||||
Revenues |
$ |
1,337.0 |
|
|
$ |
1,129.5 |
|
Cost of sales |
|
810.9 |
|
|
|
677.4 |
|
Gross Profit |
|
526.1 |
|
|
|
452.1 |
|
Selling and administrative expenses |
|
265.5 |
|
|
|
252.3 |
|
Amortization of intangible assets |
|
86.2 |
|
|
|
84.2 |
|
Other operating expense (income), net |
|
17.4 |
|
|
|
(5.7 |
) |
Operating Income |
|
157.0 |
|
|
|
121.3 |
|
Interest expense |
|
19.0 |
|
|
|
23.1 |
|
Other income, net |
|
(4.6 |
) |
|
|
(2.5 |
) |
Income from Continuing Operations Before Income Taxes |
|
142.6 |
|
|
|
100.7 |
|
Provision for income taxes |
|
32.4 |
|
|
|
10.6 |
|
Loss on equity method investments |
|
(4.3 |
) |
|
|
— |
|
Income from Continuing Operations |
|
105.9 |
|
|
|
90.1 |
|
Loss from discontinued operations, net of tax |
|
(1.4 |
) |
|
|
(180.2 |
) |
Net Income (Loss) |
|
104.5 |
|
|
|
(90.1 |
) |
Less: Net income attributable to noncontrolling interests |
|
0.8 |
|
|
|
0.3 |
|
Net Income (Loss) Attributable to |
$ |
103.7 |
|
|
$ |
(90.4 |
) |
|
|
|
|
||||
Amounts attributable to |
|
|
|
||||
Income from continuing operations, net of tax |
$ |
105.1 |
|
|
$ |
89.8 |
|
Loss from discontinued operations, net of tax |
|
(1.4 |
) |
|
|
(180.2 |
) |
Net income (loss) attributable to |
$ |
103.7 |
|
|
$ |
(90.4 |
) |
|
|
|
|
||||
Basic earnings (loss) per share of common stock: |
|
|
|
||||
Earnings from continuing operations |
$ |
0.26 |
|
|
$ |
0.21 |
|
Loss from discontinued operations |
|
— |
|
|
|
(0.43 |
) |
Net earnings (loss) |
|
0.25 |
|
|
|
(0.22 |
) |
|
|
|
|
||||
Diluted earnings (loss) per share of common stock: |
|
|
|
||||
Earnings from continuing operations |
$ |
0.25 |
|
|
$ |
0.21 |
|
Loss from discontinued operations |
|
— |
|
|
|
(0.42 |
) |
Net earnings (loss) |
|
0.25 |
|
|
|
(0.21 |
) |
CONSOLIDATED BALANCE SHEETS (Unaudited; in millions, except share amounts) |
|||||||
|
|
|
|
||||
Assets |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
1,990.2 |
|
|
$ |
2,109.6 |
|
Accounts receivable, net of allowance for credit losses of |
|
1,013.9 |
|
|
|
948.6 |
|
Inventories |
|
954.9 |
|
|
|
854.2 |
|
Other current assets |
|
217.5 |
|
|
|
186.9 |
|
Assets of discontinued operations |
|
9.5 |
|
|
|
15.6 |
|
Total current assets |
|
4,186.0 |
|
|
|
4,114.9 |
|
Property, plant and equipment, net of accumulated depreciation of |
|
635.2 |
|
|
|
648.6 |
|
|
|
5,981.4 |
|
|
|
5,981.6 |
|
Other intangible assets, net |
|
3,816.3 |
|
|
|
3,912.7 |
|
Deferred tax assets |
|
19.4 |
|
|
|
28.0 |
|
Other assets |
|
466.5 |
|
|
|
468.7 |
|
Total assets |
$ |
15,104.8 |
|
|
$ |
15,154.5 |
|
Liabilities and Stockholders' Equity |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Short-term borrowings and current maturities of long-term debt |
$ |
40.1 |
|
|
$ |
38.8 |
|
Accounts payable |
|
701.4 |
|
|
|
670.5 |
|
Accrued liabilities |
|
702.1 |
|
|
|
741.3 |
|
Liabilities of discontinued operations |
|
10.0 |
|
|
|
17.1 |
|
Total current liabilities |
|
1,453.6 |
|
|
|
1,467.7 |
|
Long-term debt, less current maturities |
|
3,375.6 |
|
|
|
3,401.8 |
|
Pensions and other postretirement benefits |
|
189.4 |
|
|
|
195.1 |
|
Deferred income taxes |
|
708.0 |
|
|
|
708.6 |
|
Other liabilities |
|
314.9 |
|
|
|
310.1 |
|
Total liabilities |
$ |
6,041.5 |
|
|
$ |
6,083.3 |
|
Stockholders' equity: |
|
|
|
||||
Common stock, |
|
4.3 |
|
|
|
4.3 |
|
Capital in excess of par value |
|
9,432.1 |
|
|
|
9,408.6 |
|
Retained earnings |
|
474.1 |
|
|
|
378.6 |
|
Accumulated other comprehensive loss |
|
(71.5 |
) |
|
|
(41.6 |
) |
|
|
(846.8 |
) |
|
|
(748.4 |
) |
Total Ingersoll Rand stockholders' equity |
$ |
8,992.2 |
|
|
$ |
9,001.5 |
|
Noncontrolling interests |
|
71.1 |
|
|
|
69.7 |
|
Total stockholders' equity |
$ |
9,063.3 |
|
|
$ |
9,071.2 |
|
Total liabilities and stockholders' equity |
$ |
15,104.8 |
|
|
$ |
15,154.5 |
|
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited; in millions) |
|||||||
|
Three Month Period
|
||||||
|
2022 |
|
2021 |
||||
Cash Flows From Operating Activities From Continuing Operations: |
|
|
|||||
Net income (loss) |
$ |
104.5 |
|
|
$ |
(90.1 |
) |
Loss from discontinued operations, net of tax |
|
(1.4 |
) |
|
|
(180.2 |
) |
Income from continuing operations |
|
105.9 |
|
|
|
90.1 |
|
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations: |
|
|
|
||||
Amortization of intangible assets |
|
86.2 |
|
|
|
84.2 |
|
Depreciation |
|
22.3 |
|
|
|
21.3 |
|
Non-cash restructuring charges |
|
2.2 |
|
|
|
— |
|
Stock-based compensation expense |
|
19.8 |
|
|
|
21.6 |
|
Loss on equity method investments |
|
4.3 |
|
|
|
— |
|
Foreign currency transaction gains, net |
|
(3.8 |
) |
|
|
(18.1 |
) |
Other non-cash adjustments |
|
2.0 |
|
|
|
(0.4 |
) |
Changes in assets and liabilities: |
|
|
|
||||
Receivables |
|
(67.7 |
) |
|
|
(46.8 |
) |
Inventories |
|
(99.4 |
) |
|
|
(50.0 |
) |
Accounts payable |
|
41.0 |
|
|
|
27.1 |
|
Accrued liabilities |
|
(37.8 |
) |
|
|
(1.4 |
) |
Other assets and liabilities, net |
|
(24.9 |
) |
|
|
(40.1 |
) |
Net cash provided by operating activities from continuing operations |
|
50.1 |
|
|
|
87.5 |
|
Cash Flows From Investing Activities From Continuing Operations: |
|
|
|
||||
Capital expenditures |
|
(17.9 |
) |
|
|
(14.3 |
) |
Net cash paid in business combinations |
|
(30.3 |
) |
|
|
(202.5 |
) |
Disposals of property, plant and equipment |
|
— |
|
|
|
9.6 |
|
Net cash used in investing activities from continuing operations |
|
(48.2 |
) |
|
|
(207.2 |
) |
Cash Flows From Financing Activities From Continuing Operations: |
|
|
|
||||
Principal payments on long-term debt |
|
(9.6 |
) |
|
|
(9.9 |
) |
Purchases of treasury stock |
|
(101.1 |
) |
|
|
(3.0 |
) |
Cash dividends on common shares |
|
(8.2 |
) |
|
|
— |
|
Proceeds from stock option exercises |
|
4.6 |
|
|
|
5.1 |
|
Payments of deferred acquisition consideration |
|
(1.8 |
) |
|
|
— |
|
Net cash used in financing activities from continuing operations |
|
(116.1 |
) |
|
|
(7.8 |
) |
Cash Flows From Discontinued Operations: |
|
|
|
||||
Net cash provided by (used in) operating activities |
|
(4.1 |
) |
|
|
34.8 |
|
Net cash used in investing activities |
|
— |
|
|
|
(1.0 |
) |
Net cash provided by (used in) discontinued operations |
|
(4.1 |
) |
|
|
33.8 |
|
Effect of exchange rate changes on cash and cash equivalents |
|
(1.1 |
) |
|
|
(17.6 |
) |
Net decrease in cash and cash equivalents |
|
(119.4 |
) |
|
|
(111.3 |
) |
Cash and cash equivalents, beginning of period |
|
2,109.6 |
|
|
|
1,750.9 |
|
Cash and cash equivalents, end of period |
$ |
1,990.2 |
|
|
$ |
1,639.6 |
|
UNAUDITED ADJUSTED FINANCIAL INFORMATION (Dollars in millions) |
|||||||
|
For the Three Month Period
|
||||||
|
2022 |
|
2021 |
||||
Ingersoll Rand |
|
|
|
||||
Revenues |
$ |
1,337.0 |
|
|
$ |
1,129.5 |
|
Adjusted EBITDA |
$ |
303.6 |
|
|
$ |
244.0 |
|
Adjusted EBITDA Margin |
|
22.7 |
% |
|
|
21.6 |
% |
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED NET INCOME (Unaudited; in millions) |
|||||||
|
For the Three Month Period
|
||||||
|
2022 |
|
2021 |
||||
Net Income (Loss) |
$ |
104.5 |
|
|
$ |
(90.1 |
) |
Less: Loss from Discontinued Operations |
|
(1.8 |
) |
|
|
(177.8 |
) |
Less: Income Tax Benefit (Provision) from Discontinued Operations |
|
0.4 |
|
|
|
(2.4 |
) |
Income from Continuing Operations |
|
105.9 |
|
|
|
90.1 |
|
Plus: |
|
|
|
||||
Provision for income taxes |
|
32.4 |
|
|
|
10.6 |
|
Amortization of acquisition related intangible assets |
|
82.6 |
|
|
|
79.6 |
|
Restructuring and related business transformation costs |
|
14.2 |
|
|
|
2.7 |
|
Acquisition related expenses and non-cash charges |
|
9.5 |
|
|
|
10.5 |
|
Stock-based compensation |
|
19.8 |
|
|
|
21.6 |
|
Foreign currency transaction gains, net |
|
(3.8 |
) |
|
|
(18.1 |
) |
Loss on equity method investments |
|
4.3 |
|
|
|
— |
|
Other adjustments |
|
(5.2 |
) |
|
|
(1.0 |
) |
Minus: |
|
|
|
||||
Income tax provision, as adjusted |
|
58.5 |
|
|
|
28.0 |
|
Adjusted Net Income |
$ |
201.2 |
|
|
$ |
168.0 |
|
RECONCILIATION OF DILUTED NET INCOME (LOSS) PER SHARE TO ADJUSTED DILUTED NET INCOME PER SHARE FROM CONTINUING OPERATIONS (Unaudited; in millions, except per share amounts) |
|||||||
|
For the Three Month Period
|
||||||
|
2022 |
|
2021 |
||||
Diluted Net Income (Loss) Per Share (As Reported)1 |
$ |
0.25 |
|
|
$ |
(0.21 |
) |
Less: Diluted Net Income (Loss) Per Share from Discontinued Operations (As Reported)1 |
|
— |
|
|
|
(0.42 |
) |
Diluted Net Income (Loss) Per Share from Continuing Operations (As Reported)1 |
|
0.25 |
|
|
|
0.21 |
|
Plus: |
|
|
|
||||
Provision for income taxes |
|
0.08 |
|
|
|
0.02 |
|
Amortization of acquisition related intangible assets |
|
0.20 |
|
|
|
0.19 |
|
Restructuring and related business transformation costs |
|
0.04 |
|
|
|
0.01 |
|
Acquisition related expenses and non-cash charges |
|
0.02 |
|
|
|
0.02 |
|
Stock-based compensation |
|
0.05 |
|
|
|
0.05 |
|
Foreign currency transaction gains, net |
|
(0.01 |
) |
|
|
(0.04 |
) |
Loss on equity method investments |
|
0.01 |
|
|
|
— |
|
Other adjustments |
|
(0.01 |
) |
|
|
— |
|
Minus: |
|
|
|
||||
Income tax provision, as adjusted |
|
0.14 |
|
|
|
0.07 |
|
Adjusted Diluted Net Income Per Share from Continuing Operations2 |
$ |
0.49 |
|
|
$ |
0.39 |
|
|
|
|
|
||||
Average shares outstanding: |
|
|
|
||||
Basic, as reported |
|
407.6 |
|
|
|
419.2 |
|
Diluted, as reported3 |
|
413.1 |
|
|
|
425.9 |
|
Adjusted diluted2 |
|
413.1 |
|
|
|
425.9 |
|
1 Basic and diluted earnings (loss) per share (as reported) are calculated by dividing net income (loss) attributable to |
2 Adjusted diluted share count and adjusted diluted earnings per share include incremental dilutive shares, using the treasury stock method, which are added to average shares outstanding. |
3 Due to net losses in certain periods shown, basic and diluted average shares outstanding are the same in those periods. |
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA AND ADJUSTED INCOME FROM CONTINUING OPERATIONS, NET OF TAX AND CASH FLOWS FROM OPERATING ACTIVITIES TO FREE CASH FLOW (Unaudited; in millions) |
|||||||
|
For the Three Month Period
|
||||||
|
2022 |
|
2021 |
||||
Net Income (Loss) |
$ |
104.5 |
|
|
$ |
(90.1 |
) |
Less: Loss from discontinued operations |
|
(1.8 |
) |
|
|
(177.8 |
) |
Less: Income tax benefit (provision) from discontinued operations |
|
0.4 |
|
|
|
(2.4 |
) |
Income from continuing operations, net of tax |
|
105.9 |
|
|
|
90.1 |
|
Plus: |
|
|
|
||||
Interest expense |
|
19.0 |
|
|
|
23.1 |
|
Provision for income taxes |
|
32.4 |
|
|
|
10.6 |
|
Depreciation expense |
|
21.3 |
|
|
|
20.3 |
|
Amortization expense |
|
86.2 |
|
|
|
84.2 |
|
Restructuring and related business transformation costs |
|
14.2 |
|
|
|
2.7 |
|
Acquisition related expenses and non-cash charges |
|
9.5 |
|
|
|
10.5 |
|
Stock-based compensation |
|
19.8 |
|
|
|
21.6 |
|
Foreign currency transaction gains, net |
|
(3.8 |
) |
|
|
(18.1 |
) |
Loss on equity method investments |
|
4.3 |
|
|
|
— |
|
Other adjustments |
|
(5.2 |
) |
|
|
(1.0 |
) |
Adjusted EBITDA |
$ |
303.6 |
|
|
$ |
244.0 |
|
Minus: |
|
|
|
||||
Interest expense |
|
19.0 |
|
|
|
23.1 |
|
Income tax provision, as adjusted |
|
58.5 |
|
|
|
28.0 |
|
Depreciation expense |
|
21.3 |
|
|
|
20.3 |
|
Amortization of non-acquisition related intangible assets |
|
3.6 |
|
|
|
4.6 |
|
Adjusted Income from Continuing Operations, Net of Tax |
$ |
201.2 |
|
|
$ |
168.0 |
|
|
|
|
|
||||
Free Cash Flow from Continuing Operations: |
|
|
|
||||
Cash flows from operating activities from continuing operations |
|
50.1 |
|
|
|
87.5 |
|
Minus: |
|
|
|
||||
Capital expenditures |
|
17.9 |
|
|
|
14.3 |
|
Free Cash Flow from Continuing Operations |
$ |
32.2 |
|
|
$ |
73.2 |
|
RECONCILIATION OF SEGMENT ADJUSTED EBITDA TO NET LOSS (Unaudited; in millions) |
|||||||
|
For the Three Month Period
|
||||||
|
2022 |
|
2021 |
||||
Orders |
|
|
|
||||
Industrial Technologies and Services |
$ |
1,292.8 |
|
|
$ |
1,042.4 |
|
Precision and Science Technologies |
|
337.1 |
|
|
|
258.2 |
|
Total Orders |
$ |
1,629.9 |
|
|
$ |
1,300.6 |
|
Revenue |
|
|
|
||||
Industrial Technologies and Services |
$ |
1,039.6 |
|
|
$ |
913.8 |
|
Precision and Science Technologies |
|
297.4 |
|
|
|
215.7 |
|
Total Revenue |
$ |
1,337.0 |
|
|
$ |
1,129.5 |
|
Segment Adjusted EBITDA |
|
|
|
||||
Industrial Technologies and Services |
$ |
247.4 |
|
|
$ |
211.5 |
|
Precision and Science Technologies |
|
85.1 |
|
|
|
67.2 |
|
Total Segment Adjusted EBITDA |
$ |
332.5 |
|
|
$ |
278.7 |
|
Less items to reconcile Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes: |
|
|
|
||||
Corporate expenses not allocated to segments |
$ |
28.9 |
|
|
$ |
34.7 |
|
Interest expense |
|
19.0 |
|
|
|
23.1 |
|
Depreciation and amortization expense |
|
107.5 |
|
|
|
104.5 |
|
Restructuring and related business transformation costs |
|
14.2 |
|
|
|
2.7 |
|
Acquisition related expenses and non-cash charges |
|
9.5 |
|
|
|
10.5 |
|
Stock-based compensation |
|
19.8 |
|
|
|
21.6 |
|
Foreign currency transaction gains, net |
|
(3.8 |
) |
|
|
(18.1 |
) |
Other adjustments |
|
(5.2 |
) |
|
|
(1.0 |
) |
Income from Continuing Operations Before Income Taxes |
|
142.6 |
|
|
|
100.7 |
|
Provision for income taxes |
|
32.4 |
|
|
|
10.6 |
|
Loss on equity method investments |
|
(4.3 |
) |
|
|
— |
|
Income from Continuing Operations |
|
105.9 |
|
|
|
90.1 |
|
Loss from discontinued operations, net of tax |
|
(1.4 |
) |
|
|
(180.2 |
) |
Net Income (Loss) |
$ |
104.5 |
|
|
$ |
(90.1 |
) |
ORDER AND REVENUE GROWTH BY SEGMENT1 |
|||||
|
For the Three Month Period
|
||||
|
Orders |
|
Revenue |
||
Ingersoll Rand |
|
|
|
||
Organic growth |
21.4 |
% |
|
13.9 |
% |
Impact of foreign currency |
(2.6 |
%) |
|
(2.3 |
%) |
Impact of acquisitions |
6.5 |
% |
|
6.8 |
% |
Total orders and revenue growth |
25.3 |
% |
|
18.4 |
% |
|
|
|
|
||
Industrial Technologies & Services |
|
|
|
||
Organic growth |
25.1 |
% |
|
14.4 |
% |
Impact of foreign currency |
(2.5 |
%) |
|
(2.1 |
%) |
Impact of acquisitions |
1.4 |
% |
|
1.5 |
% |
Total orders and revenue growth |
24.0 |
% |
|
13.8 |
% |
|
|
|
|
||
Precision & Science Technologies |
|
|
|
||
Organic growth |
6.4 |
% |
|
11.5 |
% |
Impact of foreign currency |
(3.0 |
%) |
|
(3.3 |
%) |
Impact of acquisitions |
27.2 |
% |
|
29.7 |
% |
Total orders and revenue growth |
30.6 |
% |
|
37.9 |
% |
(1) |
Organic growth/(decline), impact of foreign currency, and impact of acquisitions are non-GAAP measures. References to “impact of acquisitions” refer to GAAP sales from acquired businesses recorded prior to the first anniversary of the acquisition. The portion of GAAP revenue attributable to currency translation is calculated as the difference between (a) the period-to-period change in revenue (excluding acquisition sales) and (b) the period-to-period change in revenue (excluding acquisition sales) after applying prior year foreign exchange rates to the current year period. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220503006389/en/
Media:
mzelent@irco.com
Investor Relations:
christopher.miorin@irco.com
Source:
FAQ
What were Ingersoll Rand's first-quarter 2022 revenue figures?
How much did Ingersoll Rand raise its 2022 guidance?
What is Ingersoll Rand's net income for Q1 2022?
How much liquidity does Ingersoll Rand have as of March 31, 2022?